Key result
In a rat model of vascular surgery, sulodexide resulted in less infiltration of inflammatory cells (0.17 vs 0.67) and calcification (1.33 vs 1.67) compared to aspirin at 14 days.
Why the study?
Complications such as hazardous vascular thrombosis frequently occur after vascular surgery and require re-operations, motivating the evaluation of sulodexide compared to aspirin.
Does sulodexide reduce thrombosis and inflammation compared to aspirin in a rat model of vascular surgery?
Does sulodexide reduce thrombosis and inflammation compared to aspirin in a rat model of vascular surgery?
In a rat model of vascular surgery, sulodexide reduced postoperative calcification and inflammation compared to aspirin, with similar anti-thrombotic effects.
Should not yet change practice; leaves open sulodexide's role versus aspirin after vascular surgery in humans.
BACKGROUND: Although the number of vascular surgeries performed is increasing, the incidence of complications associated with this surgery has not improved and re-operations are frequently required. Thrombosis in a vessel is the most hazardous postoperative complication. OBJECTIVE: The aim of this study was to evaluate the anti-thrombotic and anti-inflammatory effects of sulodexide compared to aspirin in a rat model. METHODS: We divided the animals into three groups (sham (saline), aspirin, and sulodexide). The abdominal aorta was surgically opened and closed, primarily with 8/0 Prolene sutures. Postoperatively, saline, aspirin, or sulodexide was administered by oral gavage for 14 days to the rats. The degree of neovascularization, thrombus, calcification, inflammatory infiltrates, and fibrosis were analyzed histopathologically by hematoxylin and eosin staining. RESULTS: There was no significant difference in the incidence of postoperative thrombogenesis, but less calcification and inflammatory infiltrates were observed in the sulodexide group compared to the aspirin group. Histopathologic score revealed less infiltration of inflammatory cells and mild calcification for the sulodexide group (0.17±0.41 and 1.33±0.52, respectively) compared to the aspirin group (0.67±0.52 and 1.67±0.52, respectively) at days 14. CONCLUSIONS: This study offers the possibility that sulodexide could be used as an aspirin substitute for the postoperative management of vascular patients, with low gastrointestinal discomfort. In addition, it may also offer reduced postoperative calcification and inflammation.
No takes yet. Share an insight, caveat, or question.
Sohn et al. (2020) studied Vascular surgery complications (rat model). Sulodexide vs. Aspirin and saline (sham) was evaluated on Degree of neovascularization, thrombus, calcification, inflammatory infiltrates, and fibrosis. In a rat model of vascular surgery, sulodexide resulted in less infiltration of inflammatory cells (0.17 vs 0.67) and calcification (1.33 vs 1.67) compared to aspirin at 14 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: